SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-012534
Filing Date
2024-04-01
Accepted
2024-04-01 17:28:59
Documents
20
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form20-fa.htm   iXBRL 20-F/A 73434
2 ex12-1.htm EX-12.1 13320
3 ex12-2.htm EX-12.2 12780
4 ex13-1.htm EX-13.1 11668
5 ex23-1.htm EX-23.1 5725
6 ex23-1_001.jpg GRAPHIC 41429
7 ex23-1_003.jpg GRAPHIC 14757
  Complete submission text file 0001493152-24-012534.txt   474068

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE gnta-20231231.xsd EX-101.SCH 3420
9 XBRL DEFINITION FILE gnta-20231231_def.xml EX-101.DEF 30341
10 XBRL LABEL FILE gnta-20231231_lab.xml EX-101.LAB 40614
11 XBRL PRESENTATION FILE gnta-20231231_pre.xml EX-101.PRE 28479
24 EXTRACTED XBRL INSTANCE DOCUMENT form20-fa_htm.xml XML 9671
Mailing Address OLGETTINA, NO. 58 MILAN L6 20132
Business Address OLGETTINA, NO. 58 MILAN L6 20132 39-02-2643-6639
Genenta Science S.p.A. (Filer) CIK: 0001838716 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L6
Type: 20-F/A | Act: 34 | File No.: 001-41115 | Film No.: 24811213
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)